Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England

BACKGROUND: An increased risk of myocarditis or pericarditis after priming with mRNA Coronavirus Disease 2019 (COVID-19) vaccines has been shown but information on the risk post-booster is limited. With the now high prevalence of prior Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Stowe, Julia, Miller, Elizabeth, Andrews, Nick, Whitaker, Heather J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286992/
https://www.ncbi.nlm.nih.gov/pubmed/37285378
http://dx.doi.org/10.1371/journal.pmed.1004245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286992/
https://www.ncbi.nlm.nih.gov/pubmed/37285378
http://dx.doi.org/10.1371/journal.pmed.1004245

Ejemplares similares